Positron Corporation (POSC)

[JackStraw]

Most important dialogue from the May 5 conference

UNIDENTIFIED PARTICIPANT: Just in terms of your revenue projections you said you're at $200 million now and expect to be up to $5 billion in so – I forget what time frame. How much is that going to be organic growth and how much is going to be dependent upon M&A or joint ventures?


ROONEY: Well, that's a good question. No, in fact over the next three years we're looking at $200 million and the next five years $1 billion in revenue. A majority of those numbers are from organic growth, yet our acceleration will be pretty significant in the next, next 18 months as we will know the extent of our certain strategic alliances and partners that we're working. These relationships will definitely assist us on a radiopharmaceutical side that advances us significantly.


Radiopharmaceuticals could really be a – will be a game changer and certain other radiopharmaceuticals that we're dealing with now could really expand that number even greater. I mean we're in this for the long haul, obviously – even longer than five years.